But the full picture is more nuanced than that
Novo Nordisk, maker of Ozempic, has stated that patient safety is a top priority and that it encourages independent research and will continue to work with regulatory bodies regarding the safety of GLP-1 medications
Semaglutide (10 mg) is a synthetic peptide commonly studied in metabolic and endocrine research
This version of Wegovy is the first oral GLP-1 specifically approved for chronic weight management, while Rybelsus is FDA-approved for blood sugar control in adults with type 2 diabetes
Rotation guidance is intended to support appropriate injection technique
Eli Lilly is up 30.4% since the beginning of the year, and at $1,015 per share, it is trading close to its 52-week high of $1,110 from November 2025